International Clinical Trial: Sac-TMT in Vaginal and Vulvar Cancers

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07804966) titled 'Sac-TMT in Vaginal and Vulvar Cancers' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Latin American Cooperative Oncology Group

Condition: Vaginal Squamous Cell Carcinoma Vulvar Squamous Cell Carcinoma

Intervention: Drug: Sacituzumab Tirumotecan (sac-TMT)

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: January 2027

Target Sample Size: 48

Countries of Recruitment: Brazil

To know more, visit https://clinicaltrials.gov/study/NCT07...